Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024

世界の患者血液管理市場:製品別(機器(遠心分離機、輸液装置、アフェレーシス、PCR、NGS、ストレージデバイス)、アクセサリ(シリンジ、バイアル)、試薬、ソフトウェア)、コンポーネント別、エンドユーザー別(血液銀行、病院)、地域別

◆タイトル:Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
◆商品コード:MD 7481
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年12月13日
◆ページ数:197
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥593,250見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は、患者血液管理の世界市場規模が2019年107億ドルから2024年153億ドルまで年平均7.4%成長すると予測しています。本調査レポートでは、世界の患者血液管理市場を広く調査・分析し、市場概要、製品別(機器、アクセサリー、試薬&キット、ソフトウェア)分析、コンポーネント別(全血&赤血球、プラズマ)分析、エンドユーザー別(血液銀行、病院、診断クリニックおよび病理学研究所)分析、地域別分析、競合動向、企業概要などで取りまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の患者血液管理市場:製品別(機器、アクセサリー、試薬&キット、ソフトウェア)
・世界の患者血液管理市場:コンポーネント別(全血&赤血球、プラズマ)
・世界の患者血液管理市場:エンドユーザー別(血液銀行、病院、診断クリニックおよび病理学研究所)
・世界の患者血液管理市場:地域別
・競合動向
・企業概要

“The patient blood management market is projected to reach USD 15.3 billion by 2024.”
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024. The growth in this market is mainly driven by the rising number of blood donations and blood donors, surge in the prevalence of blood disorders, and rising awareness about blood transfusion safety. However, the high cost of automated instruments is expected to hinder their adoption among end users during the forecast period.

“Blood transfusion segment of instruments to register significant growth due to technological advancements.”
The product segment of the patient blood management market is segmented into instruments, accessories, reagents & kits, and software. The instrument segment is further sub-segmented into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. Technological advancements, new product launches, coupled with the increasing use of autotransfusion systems during critical surgical procedures and organ transplantation, are expected to drive the growth of this segment in the near future.

“On the basis of component, the whole blood segment commanded the leading market share in 2018.”
In terms of components, the patient blood management market is segmented into whole blood and blood components. In 2018, the whole blood segment commanded a major share of the market due to the increasing number of blood donors and blood donations across the globe. Moreover, the increasing prevalence of blood disorders such as anemia and blood cancer that require whole-blood units and RBCs for blood transfusions will further increase the demand for whole blood units, thus contributing to the market growth.

“The US patient blood management market to hold a prominent market share during the forecast period.”
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The US held the major share of the global patient blood management in 2018. Factors such as new product launches and technological advancements in patient blood management products and the presence of key players in this region are driving the growth of this market in the US. Moreover, favorable reimbursement guidelines and high awareness about blood transfusion safety will further fuel market growth.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 45%, Tier 2 – 34%, and Tier 3 – 21%
• By Designation: C-level – 47%, Director-level – 33%, and Others – 20%
• By Region: North America- 35%, Europe – 32%, APAC – 25%, Latin America- 6%, and MEA – 2%

The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.

Research Coverage
This report studies the patient blood management market based on product, component, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to individual growth trends, and it also forecasts the revenue of the market segments with respect to five mainregions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 30)
3.1 Introduction
4 Premium Insights (Page No. – 34)
4.1 Patient Blood Management Market Overview
4.2 Market, By Product
4.3 Market, By End User
4.4 Market, By Component
4.5 Market, By Region
5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Demand for Donated Blood
5.2.1.2 Increasing Number of Blood Donations and Blood Donors
5.2.1.3 Rising Prevalence of Target Diseases
5.2.1.4 Technological Advancements in the Patient Blood Management Industry
5.2.2 Restraints
5.2.2.1 High Cost Associated With Automated Systems
5.2.3 Opportunities
5.2.3.1 Market Penetration Opportunities in Developing Countries
5.2.3.2 Growing Awareness Regarding the Safety of Donated Blood
6 Patient Blood Management Market, By Product (Page No. – 43)
6.1 Introduction
6.2 Instruments
6.2.1 Blood Processing Devices
6.2.1.1 Centrifuges
6.2.1.1.1 Longer Lifespan of Centrifuge Systems to Limit the Growth of This Segment
6.2.1.2 Blood Cell Processors
6.2.1.2.1 Technological Advancements in Centrifugation Systems Might Replace Blood Cell Processors in the Near Future
6.2.2 Blood Transfusion Devices
6.2.2.1 Apheresis Machines
6.2.2.1.1 Favorable Reimbursement for Therapeutic Apheresis Procedures to Support Market Growth
6.2.2.2 Plasma & Plasma Component Separators
6.2.2.2.1 Rising Awareness and Adoption of Hiv Viral Load Testing to Support Market Growth
6.2.2.3 Cell Salvage Systems
6.2.2.3.1 High Cost of Cell Salvage Systems as Well as the Dearth of Trained Professionals to Restrain Market Growth
6.2.2.4 Other Transfusion Devices
6.2.3 Blood Culture Screening Devices
6.2.3.1 Automated Blood Culture Systems
6.2.3.1.1 Automated Blood Culture Systems Segment to Witness Higher Growth During the Forecast Period
6.2.3.2 Supporting Laboratory Equipment
6.2.3.2.1 Growing Automation to Support the Adoption of These Equipment Among End Users
6.2.4 Diagnostic & Testing Instruments
6.2.4.1 PCR Instruments
6.2.4.1.1 Significant Adoption of RT-PCR to Fuel Market Growth
6.2.4.2 Hematology Analyzers
6.2.4.2.1 Product Recalls and Safety Alerts are Expected to Restrain Market Growth
6.2.4.3 NGS Platforms
6.2.4.3.1 Rna-Seq is an Emerging Approach for Cancer Genome Testing
6.2.4.4 Blood Grouping Analyzers
6.2.4.4.1 Increasing Adoption of Blood Grouping Analyzers for Forensic Studies to Support Market Growth
6.2.5 Blood Storage Devices
6.2.5.1 Medical Refrigerators
6.2.5.1.1 Medical Refrigerators Accounted for the Largest Share of the Blood Storage Devices Market in 2018
6.2.5.2 Medical Freezers
6.2.5.2.1 Technological Advancements to Fuel Market Growth
6.3 Accessories
6.3.1 Syringes & Needles
6.3.1.1 Easy Availability and Low Cost of Syringes and Needles Driving Their Adoption
6.3.2 Vials & Tubes
6.3.2.1 Easier Sample Collection Driving the Adoption of Vials and Tubes
6.3.3 Blood Bags
6.3.3.1 Increasing Number of Blood Donations to Support Market Growth
6.3.4 Other Accessories
6.4 Reagents and Kits
6.4.1 Blood Culture Media
6.4.2 Blood Typing Reagents
6.4.3 Slide Staining Reagents
6.4.4 Assay Kits
6.4.5 Other Reagents
6.5 Software
6.5.1 Blood Bank Management Software
6.5.2 Transfusion Management Software
6.5.3 Other Software
7 Patient Blood Management Market, By Component (Page No. – 71)
7.1 Introduction
7.2 Whole Blood & Red Blood Cells
7.2.1 Growing Disease Incidence and Rising Surgical Volumes are Driving Demand for Whole Blood and Erythrocytes
7.3 Plasma
7.3.1 Expanding Applications of Blood Plasma Form a Key Driver of Market Growth
8 Patient Blood Management Market, By End User (Page No. – 74)
8.1 Introduction
8.2 Blood Banks
8.2.1 High Demand for Safe Blood is Driving the Growth of This Segment
8.3 Hospitals
8.3.1 a Large Number of Surgical Procedures Performed in These Facilities is Supporting Market Growth
8.4 Diagnostic Clinics and & Pathology Labs
8.4.1 Stringent Regulatory Compliances for Established Diagnostic Clinics & Pathology Labs is Driving the Demand for Patient Blood Management Products
9 Patient Blood Management Market, By Region (Page No. – 79)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Market Due to the Presence of Well-Developed Healthcare Infrastructure & Growing Adoption of Advanced Technologies
9.2.2 Canada
9.2.2.1 Increasing Number of Surgical Procedures Performed in the Country to Drive the Market for Patient Blood Management Products
9.3 Europe
9.3.1 Germany
9.3.1.1 Rising Geriatric Population to Fuel the Demand for Blood Transfusion
9.3.2 UK
9.3.2.1 a Large Number of Road Traffic Accidents Will Support the Growth of This Market
9.3.3 France
9.3.3.1 Budgetary Constraints are AGfecting the Sale of Advanced Automated Systems
9.3.4 Spain
9.3.4.1 Government Mandate to Deliver Safe Blood for Transfusion to Drive Market Growth
9.3.5 Italy
9.3.5.1 Increasing Awareness About the Need and Safety of Blood Transfusion Will Drive Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Well-Developed Healthcare System and Favorable Reimbursement Policy in the Country Will Propel Market Growth
9.4.2 China
9.4.2.1 China is Projected to Register Significant Growth Owing to a Large Patient Pool
9.4.3 India
9.4.3.1 Increasing Prevalence of Target Diseases is Driving the Demand for Patient Blood Management Products in the Country
9.4.4 South Korea
9.4.4.1 Government Initiatives to Support Market Growth
9.4.5 Australia
9.4.5.1 Presence of a Highly Developed Healthcare System to Contribute to Market Growth
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Growing Medical Tourism to Support the Growth of the Market in the Region
9.5.2 Mexico
9.5.2.1 Lack of Awareness About Blood Donations is Hampering Market Growth
9.5.3 Rest of Latin America
9.6 Middle East & Africa
10 Competitive Landscape (Page No. – 92)
10.1 Overview
10.2 Market Ranking Analysis, 2018
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2017–2019)
10.3.2 Product Launches (2017–2019)
10.3.3 Expansions (2017–2019)
10.3.4 Acquisitions (2017–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. – 97)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Haemonetics Corporation
11.2 Fresenius Se & Co. KGaA
11.3 Terumo Corporation
11.4 Immucor, Inc.
11.5 B. Braun Melsungen AG
11.6 Macopharma
11.7 Biomérieux SA
11.8 Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
11.9 Kaneka Corporation
11.10 Bio-Rad Laboratories, Inc.
11.11 Abbott Laboratories
11.12 Grifols, S.A.
11.13 F. Hoffmann-La Roche LTD.
11.14 Livanova PLC
11.15 Danaher Corporation
11.16 Other Companies
11.16.1 Mediware Information Systems
11.16.2 Kawasumi Laboratories, Inc.
11.16.3 Haier Biomedical
11.16.4 Diatron
11.16.5 Bag Diagnostics GmbH
*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 143)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (60 Tables)
Table 1 Leukemia Incidence and Prevalence for Key Countries, 2018
Table 2 Market, By Product, 2017–2024 (USD Million)
Table 3 Patient Blood Management Instruments Market, By Type, 2017–2024 (USD Million)
Table 4 Patient Blood Management Instruments Market, By Region, 2017–2024 (USD Million)
Table 5 Blood Processing Devices Market, By Type, 2017–2024 (USD Million)
Table 6 Blood Processing Devices Market, By Region, 2017–2024 (USD Million)
Table 7 Blood Processing Devices Market for Centrifuges, By Region, 2017–2024 (USD Million)
Table 8 Blood Processing Devices Market for Blood Cell Processors, By Region, 2017–2024 (USD Million)
Table 9 Blood Transfusion Devices Market, By Type, 2017–2024 (USD Million)
Table 10 Blood Transfusion Devices Market, By Region, 2017–2024 (USD Million)
Table 11 Medicare Unadjusted APC Payment Rates for Transfusion Procedure and Therapeutic Apheresis, 2019
Table 12 Blood Transfusion Devices Market for Apheresis Machines, By Region, 2017–2024 (USD Million)
Table 13 Blood Transfusion Devices Market for Plasma & Plasma Component Separators, By Region, 2017–2024 (USD Million)
Table 14 Blood Transfusion Devices Market for Cell Salvage Systems, By Region, 2017–2024 (USD Million)
Table 15 Blood Transfusion Devices Market for Other Transfusion Devices, By Region, 2017–2024 (USD Million)
Table 16 Blood Culture Screening Devices Market, By Type, 2017–2024 (USD Million)
Table 17 Blood Culture Screening Devices Market, By Region, 2017–2024 (USD Million)
Table 18 Blood Culture Screening Devices Market for Automated Blood Culture Systems, By Region, 2017–2024 (USD Million)
Table 19 Blood Culture Screening Devices Market for Supporting Laboratory Equipment, By Region, 2017–2024 (USD Million)
Table 20 Diagnostic & Testing Instruments Market, By Type, 2017–2024 (USD Million)
Table 21 Diagnostic & Testing Instruments Market, By Region, 2017–2024 (USD Million)
Table 22 Diagnostic & Testing Instruments Market for PCR Instruments, By Region, 2017–2024 (USD Million)
Table 23 Diagnostic & Testing Instruments Market for Hematology Analyzers, By Region, 2017–2024 (USD Million)
Table 24 Diagnostic & Testing Instruments Market for NGS Platforms, By Region, 2017–2024 (USD Million)
Table 25 Diagnostic & Testing Instruments Market for Blood Grouping Analyzers, By Region, 2017–2024 (USD Million)
Table 26 Blood Storage Devices Market, By Type, 2017–2024 (USD Million)
Table 27 Blood Storage Devices Market, By Region, 2017–2024 (USD Million)
Table 28 Blood Processing Devices Market for Medical Refrigerators, By Region, 2017–2024 (USD Million)
Table 29 Blood Processing Devices Market for Medical Freezers, By Region, 2017–2024 (USD Million)
Table 30 Patient Blood Management Accessories Market, By Type, 2017–2024 (USD Million)
Table 31 Patient Blood Management Accessories Market, By Region, 2017–2024 (USD Million)
Table 32 Patient Blood Management Accessories Market for Syringes & Needles, By Region, 2017–2024 (USD Million)
Table 33 Patient Blood Management Accessories Market for Vials & Tubes, By Region, 2017–2024 (USD Million)
Table 34 Patient Blood Management Accessories Market for Blood Bags, By Region, 2017–2024 (USD Million)
Table 35 Other Patient Blood Management Accessories Market, By Region, 2017–2024 (USD Million)
Table 36 Patient Blood Management Reagents and Kits Market, By Type, 2017–2024 (USD Million)
Table 37 Patient Blood Management Reagents and Kits Market, By Region, 2017–2024 (USD Million)
Table 38 Patient Blood Management Reagents and Kits Market for Blood Culture Media, By Region, 2017–2024 (USD Million)
Table 39 Patient Blood Management Reagents and Kits Market for Blood Typing Reagents, By Region, 2017–2024 (USD Million)
Table 40 Patient Blood Management Reagents and Kits Market for Slide Staining Reagents, By Region, 2017–2024 (USD Million)
Table 41 Patient Blood Management Reagents and Kits Market for Assay Kits, By Region, 2017–2024 (USD Million)
Table 42 Patient Blood Management Reagents and Kits Market for Other Reagents, By Region, 2017–2024 (USD Million)
Table 43 Patient Blood Management Software Market, By Type, 2017–2024 (USD Million)
Table 44 Patient Blood Management Software Market, By Region, 2017–2024 (USD Million)
Table 45 Blood Bank Management Software Market, By Region, 2017–2024 (USD Million)
Table 46 Transfusion Management Software Market, By Region, 2017–2024 (USD Million)
Table 47 Other Patient Blood Management Software Market, By Region, 2017–2024 (USD Million)
Table 48 Patient Blood Management Market, By Component, 2017–2024 (USD Million)
Table 49 Market for Whole Blood & Red Blood Cells, By Region, 2017–2024 (USD Million)
Table 50 Market for Plasma, By Region, 2017–2024 (USD Million)
Table 51 Market, By End User, 2017–2024 (USD Million)
Table 52 Market for Blood Banks, By Region, 2017–2024 (USD Million)
Table 53 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 54 Market for Diagnostic Clinics & Pathology Labs, By Region, 2017–2024 (USD Million)
Table 55 Market, By Region, 2017–2024 (USD Million)
Table 56 North America: Market, By Country, 2017–2024 (USD Million)
Table 57 North America: Market, By Component, 2017–2024 (USD Million)
Table 58 Europe: Market, By Country, 2017–2024 (USD Million)
Table 59 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 60 Latin America: Market, By Country, 2017–2024 (USD Million)

List of Figures (34 Figures)

Figure 1 Patient Blood Management Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market: Product-Based Estimation
Figure 5 Market: End User-Based Estimation
Figure 6 Market: Data Triangulation
Figure 7 Patient Blood Mangement Market, By Product, 2019 Vs. 2024 (USD Million)
Figure 8 Patient Blood Mangement Market, By Component, 2019 Vs. 2024 (USD Million)
Figure 9 Patient Blood Management Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 10 Patient Blood Mangementmarket, By Region, 2019–2024
Figure 11 Increasing Demand for Donated Blood to Drive Market Growth
Figure 12 Instruments to Dominate the Patient Blood Management Products Market During the Forecast Period
Figure 13 Blood Banks to Account for the Largest Share of the Market in 2024
Figure 14 Whole Blood & Rbcs to Account for the Largest Share of the Market, By Component
Figure 15 APAC Market to Witness the Highest Growth During the Forecast Period (2019–2024)
Figure 16 Market: Drivers, Restraints, and Opportunities
Figure 17 Rates of Road Traffic Deaths Per 100,000 Population, 2013 vs 2016
Figure 18 Canada: Number of Surgical Procedures, 2014–2017
Figure 19 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2016 and 2019
Figure 20 Patient Blood Management Market Ranking Analysis, By Key Player, 2018
Figure 21 Competitive Leadership Mapping
Figure 22 Haemonetics Corporation: Company Snapshot
Figure 23 Fresenius Se & Co. KGaA: Company Snapshot
Figure 24 Terumo Corporation: Company Snapshot
Figure 25 B. Braun Melsungen AG: Company Snapshot
Figure 26 Biomérieux SA: Company Snapshot
Figure 27 Asahi Kasei Medical Co. Ltd.: Company Snapshot
Figure 28 Kaneka Corporation: Company Snapshot
Figure 29 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 30 Abbott Laboratories: Company Snapshot
Figure 31 Grifols, S.A.: Company Snapshot
Figure 32 F. Hoffmann-La Roche LTD.: Company Snapshot
Figure 33 Livanova PLC: Company Snapshot
Figure 34 Danaher Corporation: Company Snapshot

★調査レポート[世界の患者血液管理市場:製品別(機器(遠心分離機、輸液装置、アフェレーシス、PCR、NGS、ストレージデバイス)、アクセサリ(シリンジ、バイアル)、試薬、ソフトウェア)、コンポーネント別、エンドユーザー別(血液銀行、病院)、地域別] ( Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024 / MD 7481) 販売に関する免責事項
[世界の患者血液管理市場:製品別(機器(遠心分離機、輸液装置、アフェレーシス、PCR、NGS、ストレージデバイス)、アクセサリ(シリンジ、バイアル)、試薬、ソフトウェア)、コンポーネント別、エンドユーザー別(血液銀行、病院)、地域別] ( Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024 / MD 7481) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆